![]() | ||
| Volume 35, 2 April 2004 | 4/2004 | |
| SPOT ON | |
Adjuvant treatment of breast cancer: early switch to exemestane (AROMASIN)? | |
| NEW ON THE MARKET | |
Fulvestrant (FASLODEX) for advanced breast cancer | |
| REVIEW | |
Drug-eluting stents | |
| THERAPIES FROM A CRITICAL VIEW POINT | |
Infliximab (REMICADE) for fistulising CROHN's disease | |
| QUALITY ASSESSMENT | |
Quality of enalapril (e.g. PRES) products | |
| BEWARE! MISSINFORMATION | |
Pimecrolimus (e.g. ELIDEL) for atopic dermatitis | |
| IN BRIEF | |
Prematurity and chronic lung disease: late outcomes of dexamethasone therapy | |
| CURRENT ADR NETWORK REPORT | |
|
|
Long-acting injectable risperidone (RISPERDAL CONSTA): |
|
© arznei-telegramm 4/2004 | ||
|
| ||